CMANY
SZYM

Capital Management Associates (New York)’s SOLAZYME INC COM STK (DE) SZYM Stock Holding History

Capital Management Associates (New York)’s Portfolio SZYM Stock Details SZYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-13,300
Closed -$34K – 158
2014
Q4 		$34K Sell
13,300
-32,000
-71% -$140K 0.05% 131
2014
Q3 		$338K Buy
+45,300
New +$423K 0.51% 98

Other funds holding SZYM

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
PC
Passport Capital San Francisco, California $394M AUM 50.67% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Capital Management Associates (New York)'s SZYM Position: Q1 2015 in Review

Capital Management Associates (New York) sold out of SOLAZYME INC COM STK (DE) (SZYM) in Q1 2015, closing a stake of 13,300 shares — an estimated $34K sold.

Capital Management Associates (New York) first reported a position in SZYM in Q3 2014 and held it in 2 quarters. The position peaked at $338K in Q3 2014. 102 funds tracked by Wall St. Rank hold SZYM as of Q1 2015.

  • Capital Management Associates (New York) reported no remaining SOLAZYME INC COM STK (DE) position as of Q1 2015 after selling out during the quarter.
  • Capital Management Associates (New York) sold 13,300 SOLAZYME INC COM STK (DE) shares in Q1 2015, an estimated $34K.
  • Capital Management Associates (New York) first reported a position in SOLAZYME INC COM STK (DE) in Q3 2014 and held it in 2 quarters.
  • Capital Management Associates (New York)'s SOLAZYME INC COM STK (DE) position peaked at $338K in Q3 2014.
  • 102 funds tracked by Wall St. Rank held SOLAZYME INC COM STK (DE) as of Q1 2015.

Based on Capital Management Associates (New York)'s 13F filing for Q1 2015, filed 21 May 2015.